Clinical Insights
about usprincipal investigatorclinical trialsinterest formdirections
About Us
Clinical Trials ExperienceAssessment ExperiencePharmaceutical Sponsors

Clinical Trials Experience


  • A 12 Week, Double-Blind, Fixed Dose Comparison of 20 and 40 mg daily of Study Drug and Placebo in Patients Suffering from Posttraumatic Stress Disorder (PTSD).

  • Placebo-Controlled Study of the Safety and Efficacy of Study Drug in the Treatment of Acute
    Manic or Mixed Episodes in Subjects with Bipolar I Disorder.

  • Open-Label Extension Study of the Safety and Tolerability of Study Drug in Subjects with
    Bipolar Disorderwho Completed Protocol Study Drug.

  • Study Drug for the Treatment of Tardive Dyskinesia in Schizophrenic Patients.

  • The Combination of Study Drug and Study Drug in Treatment Resistant Depression without
    Psychotic Features.

  • A Placebo-Controlled Study of Study Drug and Paroxetine in Patients with Panic Disorder

  • Open-Label Safety Study of Study Drug Patients with Anxiety Disorders

  • A Randomized, Double-Blind, Placebo- and Risperidone-Controlled, Multicenter Study to
    Evaluate the Efficacy and Safety of Two Nonoverlapping Dose Ranges of Study Drug given BID for 42 days to Schizophrenic Patients with Acute or Subacute Exacerbation, Followed by a Risperidone-Controlled, Long-Term Treatment Phase with Study Drug given QD.

  • The Comparative Efficacy of Study Drug, Risperidone, and Haloperidol for Cognition in

  • A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Three Fixed Doses of Study Drug in the Treatment of Institutionalized Patients with Psychosis Associated with
    Dementia of the Alzheimer's Type.

  • A Double-Blind, Placebo-Controlled, 3-Arm Fixed Dose Study of Study Drug Continuous
    Treatment for Premenstrual Dysphoric Disorder.

back to top

1987 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006

| about us | principal investigator | clinical trials | interest form | directions | contact

Clinical Insights
Clinical Insights
Clinical Insights 1600 Crain Highway South - Suite 601 - Glen Burnie, MD 21061 - 410.768.2629 Clinical Insights 1600 Crain Highway South - Suite 601 - Glen Burnie, MD 21061 - 410.768.2629